Covid-19

Stress and Smoking Rates Up Among All Hospital Workers, New Hebrew U. Study Finds

A new study, published in the leading journal Nicotine and Tobacco Research’s special issue devoted to smoking and COVID-19, found that being on the COVID-19 frontlines could negatively impact hospital workers’ mental health—even during lull periods and even for ancillary hospital staff, such as maintenance workers and administrative staff.  

Hebrew University study shows lipid-lowering drug reduced inflammation in 48 hours and removed the need for oxygen support within 5 to 7 days for hospitalized COVID-19 patients.

The SARS-CoV-2 virus has infected over 165 million people worldwide causing nearly 3.5 million deaths. Recent vaccination efforts have been hindered by multiple coronavirus variants that challenge current vaccines. While infection generally produces a mild disease, in some patients it can develop into a severe inflammatory COVID-19 requiring medical intervention.

Hebrew University Study Analyzes How Corona Has Changed How We Remember

“This global crisis created a far more accepting culture for the role digital media must play in remembrance.”

The researchers’ updated analysis: “preparations must be carried out for tightening the current restrictions. Given the current rate of infection, another outbreak will be significantly worse than the first.” They are not warning of a separate wave, but rather a resurgence of the second wave. 

The Edmond de Rothschild Foundation has generously provided the Hebrew University of Jerusalem (HU) with 15 million NIS to fund coronavirus research.  The donation will fund 60 research teams at HU that are working to find a vaccine, produce faster and cheaper testing methods, and develop targeted treatments for those afflicted by COVID-19. 

Join us for this special webinar series and learn directly from some of Hebrew University’s greatest minds about the implications of the coronavirus.

1. The Real Risk Of The Spread Of The CoronaVirus (French). Register Here.

2. Don't Panic: Dealing With Anxiety In The Age Of Coronavirus (English). Register Here.

Promising Hebrew University - Mount Sinai Research Shows Coronavirus Causes Lungs to Accumulate Fat; Cholesterol-Lowering Drug May Hold Key to Stopping COVID-19 in its Tracks. 

Could a simple drug, that has been on the market for decades, be used to treat COVID-19?  A research team led by Hebrew University of Jerusalem (HU)’s Professor Yaakov Nahmias says that early research looks promising; their findings appear in this week’s Cell Press’ Sneak Peak.

Global Survey of 4,000 Coronavirus Patients Supports Link Between COVID-19 and Loss of Smell and Taste

Join us for this special webinar series and learn directly from some of Hebrew University’s greatest minds about the implications of
the coronavirus.

1. Financial Implications of the Pandemic, Featuring Prof. Dan Galai

Monday, March 23, 20:00 Jerusalem time - Register Here.

Prof. Emeritus, the Jerusalem School of Business Administration, The Hebrew University of Jerusalem